Skip to content

Study on the Correlation Between Extracellular Fluid Viscosity and NETosis in ARDS Pulmonary Injury

Study on the Correlation Between Extracellular Fluid Viscosity and NETosis in ARDS Pulmonary Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111164
Enrollment
Unknown
Registered
2025-10-27
Start date
2025-10-30
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Interventions

Trial group:None

Sponsors

The First People’s Hospital of Lianyungang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years and <= 80 years, gender not restricted; 2. Within one week of onset, there are known clinical manifestations of respiratory system impairment or new/accelerated respiratory symptoms; 3. Chest imaging suggests weakened lung transparency, which cannot be fully explained by pleural effusion, lobar pneumonia, atelectasis, pulmonary nodules, etc. 4. Respiratory failure cannot be fully explained by heart failure or fluid overload, and excludes pulmonary edema caused by increased hydrostatic pressure; 5. Blood gas analysis: P/F <= 300 mmHg; 6. Undergoing invasive mechanical ventilation treatment; 7. Need for fiberoptic bronchoscopy examination or treatment; 8. The patient or legal representative signs the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Patients with underlying diseases whose expected survival time is less than 28 days, such as terminal malignant tumors, cardiac arrest within 30 days before enrollment, terminal lung diseases, etc. 3. Patients with severe diseases such as severe heart failure (NYHA class IV), chronic obstructive pulmonary disease, long-term kidney dialysis, liver failure, immunosuppression, etc. 4. Patients whose attending doctors consider not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Extracellular fluid viscosity;

Countries

China

Contacts

Public ContactRuwei Huo

The First People’s Hospital of Lianyungang

ruweihuo@163.com+86 178 0512 0080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026